Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
APT Alpha Pro Tech	$4.73 -0.2%	$4.56	$4.06 ▼ $6.44	$51.39M	0.34	29,264 shs	16,315 shs
CATX Perspective Therapeutics	$3.76 +3.9%	$2.82	$1.60 ▼ $16.55	$279.10M	1.09	1.07 million shs	4.16 million shs
DRTS Alpha Tau Medical	$2.98 -1.3%	$2.89	$1.93 ▼ $4.39	$252.76M	0.99	49,088 shs	52,082 shs
INGN Inogen	$7.08 -1.7%	$6.63	$5.70 ▼ $13.33	$190.38M	1.65	243,107 shs	358,961 shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
APT Alpha Pro Tech	0.00%	-0.42%	+0.21%	-5.40%	-14.00%
CATX Perspective Therapeutics	0.00%	+8.67%	+46.30%	+76.53%	-62.29%
DRTS Alpha Tau Medical	0.00%	+2.76%	+0.68%	+18.73%	+17.79%
INGN Inogen	0.00%	+6.63%	+9.94%	-0.70%	-12.92%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
APT Alpha Pro Tech	1.5868 of 5 stars	0.0	3.0	0.0	2.9	0.8	1.9
CATX Perspective Therapeutics	2.3059 of 5 stars	3.6	1.0	0.0	3.1	2.5	0.0
DRTS Alpha Tau Medical	2.5233 of 5 stars	3.5	3.0	0.0	3.0	1.7	0.0
INGN Inogen	4.2616 of 5 stars	3.3	4.0	3.9	1.4	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
APT Alpha Pro Tech	0.00	N/A	N/A	N/A
CATX Perspective Therapeutics	3.18	Buy	$12.56	233.92% Upside
DRTS Alpha Tau Medical	3.00	Buy	$8.00	168.46% Upside
INGN Inogen	2.50	Moderate Buy	$11.00	55.37% Upside

Current Analyst Ratings Breakdown

Latest APT, INGN, DRTS, and CATX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/23/2025	CATX Perspective Therapeutics	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$9.00 ➝ $12.00
6/23/2025	CATX Perspective Therapeutics	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$11.00
6/16/2025	INGN Inogen	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$14.00
6/15/2025	INGN Inogen	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$14.00
6/3/2025	CATX Perspective Therapeutics	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Outperform ➝ Moderate Buy	$15.00 ➝ $16.00
5/22/2025	INGN Inogen	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Moderate Buy	$12.00
5/14/2025	CATX Perspective Therapeutics	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$10.00 ➝ $8.00
5/13/2025	CATX Perspective Therapeutics	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform	$11.00
5/8/2025	INGN Inogen	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$10.00 ➝ $7.00
4/29/2025	DRTS Alpha Tau Medical	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$9.00 ➝ $9.00
4/9/2025	INGN Inogen	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold

(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
APT Alpha Pro Tech	$58.18M	0.88	$0.37 per share	12.80	$5.29 per share	0.89
CATX Perspective Therapeutics	N/A	N/A	N/A	N/A	$2.67 per share	N/A
DRTS Alpha Tau Medical	N/A	N/A	N/A	N/A	$0.89 per share	N/A
INGN Inogen	$335.70M	0.57	N/A	N/A	$7.30 per share	0.97

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
APT Alpha Pro Tech	$4.19M	$0.37	12.78	∞	N/A	6.99%	6.70%	5.76%	N/A
CATX Perspective Therapeutics	-$46.51M	N/A	0.00	N/A	N/A	-4,096.66%	-27.40%	-23.16%	8/11/2025 (Estimated)
DRTS Alpha Tau Medical	-$31.75M	-$0.46	N/A	N/A	N/A	N/A	-49.48%	-36.69%	8/13/2025 (Estimated)
INGN Inogen	-$35.89M	-$1.15	N/A	N/A	N/A	-8.08%	-14.76%	-9.01%	8/5/2025 (Estimated)

Latest APT, INGN, DRTS, and CATX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
5/19/2025	Q1 2025	DRTS Alpha Tau Medical	-$0.14	-$0.12	+$0.02	-$0.12	$0.03 million	N/A
5/7/2025	Q1 2025	INGN Inogen	-$0.52	-$0.25	+$0.27	-$0.25	$79.57 million	$82.28 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
APT Alpha Pro Tech	N/A	N/A	N/A	N/A	N/A
CATX Perspective Therapeutics	N/A	N/A	N/A	N/A	N/A
DRTS Alpha Tau Medical	N/A	N/A	N/A	N/A	N/A
INGN Inogen	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
APT Alpha Pro Tech	N/A	19.00	11.21
CATX Perspective Therapeutics	N/A	9.60	9.60
DRTS Alpha Tau Medical	0.10	5.81	5.81
INGN Inogen	N/A	3.07	2.67

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
APT Alpha Pro Tech	22.69%
CATX Perspective Therapeutics	54.66%
DRTS Alpha Tau Medical	2.65%
INGN Inogen	89.94%

Insider Ownership

Company	Insider Ownership
APT Alpha Pro Tech	15.00%
CATX Perspective Therapeutics	3.72%
DRTS Alpha Tau Medical	39.50%
INGN Inogen	1.46%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
APT Alpha Pro Tech	120	10.86 million	9.46 million	Optionable
CATX Perspective Therapeutics	70	74.23 million	65.21 million	Optionable
DRTS Alpha Tau Medical	80	84.82 million	51.32 million	No Data
INGN Inogen	1,030	26.89 million	26.49 million	Optionable

APT, INGN, DRTS, and CATX Headlines

Recent News About These Companies

Inogen-Yuwell launch new stationary oxygen concentrator

June 24, 2025 | hmenews.comH

Inogen-Yuwell launch new stationary oxygen concentrator

June 24, 2025 | hmenews.comH

Inogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen Therapy

June 23, 2025 | businesswire.com

What is B. Riley's Forecast for Inogen Q2 Earnings?

June 18, 2025 | marketbeat.com

Inogen (NASDAQ:INGN) Upgraded by B. Riley to "Strong-Buy" Rating

June 17, 2025 | marketbeat.com

Inogen (INGN) Stock Coverage Initiated by B. Riley Securities | INGN Stock News

June 16, 2025 | gurufocus.com

Inogen: Still Breathing, But Margin Pressures Persist

June 16, 2025 | seekingalpha.com

Inogen (NASDAQ:INGN) Coverage Initiated by Analysts at B. Riley

June 16, 2025 | marketbeat.com

Inogen (INGN) Initiated with Buy Rating by B. Riley Analyst | INGN Stock News

June 16, 2025 | gurufocus.com

Inogen (INGN) Receives Buy Rating and $14 Target from B. Riley | INGN Stock News

June 15, 2025 | gurufocus.com

Here’s Why Brown Capital Management Small Company Fund Sold Inogen (INGN) in Q1

June 10, 2025 | insidermonkey.com

Two Sigma Advisers LP Lowers Holdings in Inogen, Inc. (NASDAQ:INGN)

June 8, 2025 | marketbeat.com

Inogen (INGN) Down 0.8% Since Last Earnings Report: Can It Rebound?

June 7, 2025 | msn.com

46,224 Shares in Inogen, Inc. (NASDAQ:INGN) Purchased by Squarepoint Ops LLC

June 5, 2025 | marketbeat.com

Millennium Management LLC Acquires 88,924 Shares of Inogen, Inc. (NASDAQ:INGN)

June 5, 2025 | marketbeat.com

With 72% ownership of the shares, Inogen, Inc. (NASDAQ:INGN) is heavily dominated by institutional owners

May 30, 2025 | finance.yahoo.com

Here's Why You Should Add Inogen Stock to Your Portfolio Now

May 28, 2025 | zacks.com

Zacks.com featured highlights Urban Outfitters, Inogen and Southwest Gas

May 28, 2025 | finance.yahoo.com

3 Stocks With Upgraded Broker Ratings to Bet on Amid Uncertainties

May 27, 2025 | zacks.com

Inogen shares upgraded to Buy at Needham, $12 price target set

May 24, 2025 | uk.investing.com

Needham Upgrades Inogen (INGN) to Buy

May 23, 2025 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
By Dan Schmidt | June 20, 2025
View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
By Gabriel Osorio-Mazilli | June 23, 2025
View BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
AST SpaceMobile’s Star Is Rising: Get in While It’s Still Cheap!
By Thomas Hughes | June 16, 2025
View AST SpaceMobile’s Star Is Rising: Get in While It’s Still Cheap!
Marvell's New AI Chip Deals Capture Wall Street’s Attention
By Jeffrey Neal Johnson | June 21, 2025
View Marvell's New AI Chip Deals Capture Wall Street’s Attention
3 Nuclear ETFs to Watch as U.S. Policy Sparks a Surge
By Nathan Reiff | June 9, 2025
View 3 Nuclear ETFs to Watch as U.S. Policy Sparks a Surge

APT, INGN, DRTS, and CATX Company Descriptions

Alpha Pro Tech NYSE:APT

$4.73 -0.01 (-0.21%)

Closing price 06/27/2025 04:00 PM Eastern

Extended Trading

$6.22 +1.50 (+31.61%)

As of 04:00 AM Eastern

Alpha Pro Tech, Ltd., together with its subsidiaries, develops, manufactures, and markets a range of disposable protective apparel, infection control, and building supply products in the United States and internationally. The company operates through Disposable Protective Apparel and Building Supply segments. The Disposable Protective Apparel segment provides shoe covers, bouffant caps, coveralls, frocks, lab coats, and gowns, hoods, as well as face masks and shields. The Building Supply segment offers construction weatherization products, such as housewrap and housewrap accessories, including window and door flashing, and seam tape, synthetic roof underlayment, and self-adhered roof underlayment, as well as other woven material. The company markets its products under the Alpha Pro Tech brand name, as well as under private labels. Its products are used primarily in cleanrooms; industrial safety manufacturing environments; health care facilities, such as hospitals, laboratories, and dental offices; building and re-roofing sites. The company distributes its products through a network of purchasing groups, distributors, and independent sales representatives, as well as through its sales and marketing force. Alpha Pro Tech, Ltd. was founded in 1983 and is headquartered in Markham, Canada.

Perspective Therapeutics NYSE:CATX

$3.76 +0.14 (+3.87%)

Closing price 06/27/2025 04:00 PM Eastern

Extended Trading

$3.74 -0.02 (-0.66%)

As of 04:12 AM Eastern

Perspective Therapeutics, Inc., together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. The company discovers, designs, and develop its initial programs candidates consists of VMT-a-NET, that is currently in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2) expressing tumors that have not previously received peptide-targeted radiopharmaceutical therapy, such as Lutathera, a beta-emitting therapy; and VMT01, which is currently in Phase 1/2a clinical trials for second-line or later treatment of patients with progressive melanocortin 1 receptor (MC1R) positive metastatic melanoma. Perspective Therapeutics, Inc. has a clinical trial collaboration agreement with Bristol Myers Squibb to evaluate the safety and tolerability of [212Pb] VMT01 in combination with nivolumab in patients with histologically confirmed melanoma and positive MC1R imaging scans. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is headquartered in Seattle, Washington.

Alpha Tau Medical NASDAQ:DRTS

$2.98 -0.04 (-1.32%)

Closing price 06/27/2025 03:55 PM Eastern

Extended Trading

$3.09 +0.11 (+3.66%)

As of 04:13 AM Eastern

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Inogen NASDAQ:INGN

$7.08 -0.12 (-1.67%)

Closing price 06/27/2025 04:00 PM Eastern

Extended Trading

$7.18 +0.10 (+1.41%)

As of 04:00 AM Eastern

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time